Cellular Molecule Barcoding Through In Situ cDNA Tagging

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for sequencing individual transcripts from cells are complex, require specialized equipment, or are limited in scalability and accuracy, especially when dealing with large samples.

Innovation Solution

A method involving the in situ reverse transcription of RNA into cDNA, followed by the ligation of nucleic acid tags to form unique barcodes, allowing for the separation and labeling of individual cells in separate reaction vessels, and repeated rounds of tagging and pooling to ensure each cell has a unique barcode.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If manual separation of individual cells into separate reaction vessels is used, then individual cell sequencing can be achieved, but the process becomes too complicated and requires specialized equipment

Engineering Contradiction:
Improveindividual cell sequencing accuracyVSAvoidspecialized equipment requirement
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent introduces barcodes as intermediary molecules that mediate between individual cells and sequencing analysis. Instead of physically separating and analyzing each cell individually through complex equipment, barcodes are attached to cDNA from individual cells, allowing pooled sequencing where barcode sequences serve as identifiers linking reads back to their source cells, thereby simplifying the experimental workflow while maintaining individual cell resolution

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent creates informational copies of cell identity through barcode sequences. Rather than physically isolating and sequencing each cell's complete transcriptome separately, the method generates barcode copies that represent each cell's identity, which can then be read alongside pooled cDNA sequences to reconstruct individual cell transcriptomes from bulk sequencing data

Inventive Principle:
Principle #26Copying

2Measurement precision

If microscopy is used to identify individual fluorescent bases, then sequencing can be performed, but the technique is difficult to implement and limited to sequencing a low number of cells

Engineering Contradiction:
Improvebase identification accuracyVSAvoidnumber of cells that can be sequenced
Core Design Contradiction:
Measurement precisionVSProductivity

Solution Approach 1:

The patent combines multiple cells' cDNA into a single pooled sample for bulk sequencing, rather than sequencing individual cells separately through microscopy. By attaching unique barcodes to each cell's cDNA before pooling, the method achieves both high-throughput processing of many cells simultaneously and accurate base identification through standard high-accuracy sequencing chemistry

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The patent adds an informational dimension through barcode sequences that encode cell identity. This allows the system to handle high-dimensional data from many cells simultaneously through bulk sequencing, rather than being constrained to low-dimensional, sequential imaging of individual cells. The barcode dimension enables computational deconvolution of pooled signals back to individual cell sources

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

3Productivity

If all cDNA sequences are mixed together before sequencing, then NGS can be performed efficiently, but RNA expression cannot be linked back to individual cells

Engineering Contradiction:
Improvesequencing efficiencyVSAvoidindividual cell origin information
Core Design Contradiction:
ProductivityVSLoss of information

Solution Approach 1:

The patent uses barcodes as intermediary markers that travel with cDNA through the pooling and sequencing process. These barcode sequences are co-sequenced with the cDNA, serving as informational tags that enable computational association of sequencing reads with their source cells even though the physical samples are mixed together during bulk processing

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent implements a feedback mechanism where barcode sequences from the pooled sequencing output provide information that feeds back into the data analysis pipeline. By reading and decoding barcode sequences from the bulk sequencing data, the system can computationally reassign reads to their source cells, thereby recovering individual cell information from pooled sequencing results

Inventive Principle:
Principle #23Feedback

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables the sequencing of RNA expression at the level of individual cells, providing a high likelihood of unique barcodes for each cell, facilitating accurate transcriptome analysis.

Implementation Method 1

conversion of the RNA transcripts into complementary DNA (cDNA) using reverse transcription

Methodology Applied
Scientific EffectReverse transcription: Enzyme

Implementation Method 2

ligation of nucleic acid tags to form unique barcodes, allowing for the separation and labeling of individual cells

Methodology Applied
Scientific EffectNucleic acid hybridization: Chemical Bonding

Data Source

PatentUS12428671B2Methods and kits for labeling cellular molecules
Publication Date: 2025.09.30 UNIV OF WASHINGTON
  • US12428671B2 patent drawing
  • US12428671B2 patent drawing
  • US12428671B2 patent drawing

AI summary

Methods of uniquely labeling or barcoding molecules within a cell, a plurality of cells, and/or a tissue are provided. Kits for uniquely labeling or barcoding molecules within a cell, a plurality of cells, and/or a tissue are also provided. The molecules to be labeled may include, but are not limited to, RNAs, cDNAs, DNAs, proteins, peptides, and/or antigens.